跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 4,072 条关于
“PBD”
全部
4,072
临床试验
3,241
药物
334
机构
19
资讯
478
去年
Novel ALK-Targeted Antibody-Drug Conjugate Demonstrates Complete Tumor Regression in Preclinical Cancer Models
去年
CStone Advances CS5001 ROR1-ADC to Phase Ib Trial for First-line DLBCL Treatment
去年
Daiichi Sankyo Presents Breakthrough ENHERTU Data at ASCO 2025 with Two Late-Breaking Phase 3 Trials
去年
ADC Therapeutics' Zynlonta Faces Competition, Poised for Potential Second-Line DLBCL Approval
2年前
Daiichi Sankyo's DS-9606 Shows Promise in Phase I Trial for Advanced Solid Tumors
去年
ADC Therapeutics Completes Enrollment in Phase 3 LOTIS-5 Trial for Zynlonta in Relapsed/Refractory DLBCL
2年前
Daiichi Sankyo's DS-9606 Shows Promise in Phase I Solid Tumor Trial
去年
Iksuda Therapeutics Initiates First-in-Human Trial of CD19-Targeted ADC IKS03 for Advanced B-Cell Non-Hodgkin Lymphoma
去年
Probiotics Show Promise in Mitigating Toxic Effects of Fire Retardant Chemicals
2年前
Daiichi Sankyo's DS-9606 Shows Early Promise in Advanced Solid Tumors Expressing CLDN6
第 1 页,共 48 页
上一页
下一页